Rnav8 BIO
Laguna Niguel, US · Founded 2022 · Delaware corporation · 6 employees on LinkedIn · 4 known investors
Find your way into Rnav8 BIO
186 people in our graph share verified history with the Rnav8 BIO team — schools, employers, funds. One of them is your warm intro.
Drew Oettingunlockedknows Devan Shah · together at Resilience (overlapped)
knows the team · via Resilience
knows the team · via 3Scan
knows the team · via The Brattle Group
×4knows the team · via The George Washington University School of Business
×3knows the team · via City University of Hong Kong
RNAV8 Bio develops a toolkit for engineering mRNA therapeutics, optimizing non-coding sequences to improve expression and efficacy of mRNA-based treatments. The company serves pharmaceutical and biotech organizations seeking to expand the clinical application of mRNA technology.
Founders & leadership
Rnav8 BIO was founded in 2022 by Devan Shah and Michelle Lynn Hall.
DS
Devan ShahinDevan Shah brings expertise in nucleic acids, regenerative medicine, and computational biology, along with experience in business development, operations, and finance. He is co-founder and CEO of RNAV8 Bio, which develops optimization tools for mRNA therapeutics.
ML
Michelle Lynn Hall
Investors · 4
Reported raises · per SEC filings
Form D private placements$2M disclosed across 1 round · 2022
▶$2MraisedMar 2025 · 42 investors · BiotechnologyRule 506(b)
▶$2MraisedMar 2025 · 42 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Devan ShahExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $2M
- First sale
- May 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Rnav8 BIO do?
- RNAV8 Bio develops a toolkit for engineering mRNA therapeutics, optimizing non-coding sequences to improve expression and efficacy of mRNA-based treatments. The company serves pharmaceutical and biotech organizations seeking to expand the clinical application of mRNA technology.
- Who founded Rnav8 BIO?
- Rnav8 BIO was founded by Devan Shah, Michelle Lynn Hall in 2022.
- Who are Rnav8 BIO's investors?
- Rnav8 BIO's investors include BioBrit, Elmehøj Ventures, Portal Innovations, Service Provider Capital.
- How much funding has Rnav8 BIO raised?
- Rnav8 BIO has disclosed $2M raised across 1 round.
- Where is Rnav8 BIO headquartered?
- Rnav8 BIO is headquartered in Laguna Niguel, US.